Stevanato Group S.p.A. reported €1.19B of revenue over the trailing twelve months, +7.4% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: €1.19B (to FY2025). Net income: €140M, trailing twelve months to FY2025. Free cash flow: €22M, trailing twelve months to FY2025. Operating margin: 17%, trailing twelve months to FY2025.

STVNStevanato Group S.p.A.

Healthcare

$19.38-27% 1Y

$19.38

$13.3852 weeks$27.51

STVN as reported

Stevanato Group S.p.A. reported €1.19B of revenue over the trailing twelve months, +7.4% on the year before. 10 reported series are charted on this page, each one as filed.

€1.19B

Revenue, trailing twelve months · to FY2025 · +7.4% against the twelve months before

Net income: €140M
Net income · +19% year on year · trailing twelve months to FY2025
Free cash flow: €22M
Free cash flow · −115% year on year · trailing twelve months to FY2025
Operating margin: 17%
Operating margin · trailing twelve months to FY2025

Details›

Every series Ryufin has for STVN, trailing twelve months
Series	Latest	Year on year	As of
Revenue	€1.19B	+7.4%	FY2025
Net income	€140M	+19%	FY2025
EPS	€0.51	+19%	FY2025
Gross margin	29%	n/a	FY2025
Operating margin	17%	n/a	FY2025
Net margin	12%	n/a	FY2025
ROE	9.4%	n/a	FY2025
ROA	5.5%	n/a	FY2025
ROIC	8.7%	n/a	FY2025
Free cash flow	€22M	−115%	FY2025

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.